✦ LIBER ✦

PDB8 FEWER TREATMENT CHANGES WITH PREMIXED INSULIN ANALOGUES COMPARED TO PREMIXED HUMAN INSULIN–A REAL-LIFE TREATMENT PATTERN ANALYSIS OF PATIENTS WITH TYPE 2 DIABETES IN THE NETHERLANDS

✍ Scribed by TL Thomsen; E Heintjes; FJA Penning; T Christensen; RMC Herings

Book ID: 118609940
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 96 KB
Volume: 13
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)72255-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB65 REAL-LIFE PRESCRIPTION PATTERNS SH

PDB65 REAL-LIFE PRESCRIPTION PATTERNS SHOW FEWER TREATMENT CHANGES WITH BASAL INSULIN ANALOGS COMPARED TO NPH IN TYPE 2 DIABETES IN THE NETHERLANDS

✍ TL Thomsen; EM Heintjes; FJA Penning-van Beest; TE Christensen; RM Herings 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

PDB40 COST-UTILITY OF BIPHASIC INSULIN A

PDB40 COST-UTILITY OF BIPHASIC INSULIN ASPART COMPARED WITH PREMIXED HUMAN INSULIN IN TREATMENT OF TYPE-2 DIABETES MELLITUS IN POLAND

✍ D Szmurlo; A Gurda-Duda; P Rys; J Rutkowski; I Skrzekowska-Baran; R Plisko; M Wl 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

The Use of Premixed Insulin Analogues in

The Use of Premixed Insulin Analogues in the Treatment of Patients with Type 2 Diabetes Mellitus: Advantages and Limitations

✍ Ali A. Rizvi; Robert J. Ligthelm 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 989 KB

Pravastatin compared to bezafibrate in t

Pravastatin compared to bezafibrate in the treatment of dyslipidemia in insulin-treated patients with Type 2 diabetes mellitus

✍ C. Rustemeijer; J. A. Schouten; H. J. Voerman; H. E. S. J. Hensgens; A. J. M. Do 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

Background Both HMG-CoA reductase inhibitors and ®bric acid derivates are used for the treatment of dyslipidemia in Type 2 diabetes patients. The aim of this study was to compare the lipid lowering effect of 40 mg pravastatin, a HMG-CoA reductase inhibitor, and 400 mg beza®brate, a ®bric acid deriva

P-28 Switching patients from human premi

P-28 Switching patients from human premix insulin to biphasic insulin aspart 30 leads to improved glycaemic control: a subgroup analysis of Korean patients with Type 2 diabetes in the PRESENT study

✍ Seung Joon Oh; Jong Hwa Kim; SukO. Park; Suk ManSon; Sun Kyung Song; So Ra Lee 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Randomized, open-label, parallel-group e

Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: A noninferiority intensification substudy of the DURABLE trial

✍ William F. Miser; Richard Arakaki; Honghua Jiang; Jamie Scism-Bacon; Pamela W. A 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 873 KB